04:37 PM EDT, 06/11/2024 (MT Newswires) -- William D. Waddill, Director, on June 07, 2024, sold 8,000 shares in Protagonist Therapeutics ( PTGX ) for $280,000. Following the Form 4 filing with the SEC, Waddill has control over a total of 12,000 shares of the company, with 12,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1377121/000110465924070420/xslF345X03/tm2416932-2_4seq1.xml

Price: 35.97, Change: +2.02, Percent Change: +5.95